156 related articles for article (PubMed ID: 22226154)
1. Intralesional interferon-α for conjunctival mucosa-associated lymphoid tissue lymphoma: long-term results.
Blasi MA; Tiberti AC; Valente P; Laguardia M; Sammarco MG; Balestrazzi A; Larocca LM; Balestrazzi E
Ophthalmology; 2012 Mar; 119(3):494-500. PubMed ID: 22226154
[TBL] [Abstract][Full Text] [Related]
2. Local chemotherapy with interferon-alpha for conjunctival mucosa-associated lymphoid tissue lymphoma: a preliminary report.
Blasi MA; Gherlinzoni F; Calvisi G; Sasso P; Tani M; Cellini M; Balestrazzi E
Ophthalmology; 2001 Mar; 108(3):559-62. PubMed ID: 11237911
[TBL] [Abstract][Full Text] [Related]
3. Intralesional interferon-α for the treatment of bilateral conjunctival mucosa-associated lymphoid tissue lymphoma.
Holds J; Buchanan A; Hanson R
Pediatr Blood Cancer; 2012 Jul; 59(1):176-8. PubMed ID: 21793177
[TBL] [Abstract][Full Text] [Related]
4. Treatment of conjunctival mucosa-associated lymphoid tissue lymphoma with intralesional injection of interferon alfa-2b.
Lachapelle KR; Rathee R; Kratky V; Dexter DF
Arch Ophthalmol; 2000 Feb; 118(2):284-5. PubMed ID: 10676800
[No Abstract] [Full Text] [Related]
5. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia.
Vann RR; Karp CL
Ophthalmology; 1999 Jan; 106(1):91-7. PubMed ID: 9917787
[TBL] [Abstract][Full Text] [Related]
6. Systemic remission of non-Hodgkin's lymphoma after intralesional interferon alpha-2b to bilateral conjunctival lymphomas.
Ross JJ; Tu KL; Damato BE
Am J Ophthalmol; 2004 Oct; 138(4):672-3. PubMed ID: 15488809
[TBL] [Abstract][Full Text] [Related]
7. A case of conjunctival MALT lymphoma: successfully treated with solely extended rituximab therapy.
Celiker H; Toker E; Kaygusuz Atagunduz I
Int Ophthalmol; 2019 Mar; 39(3):687-691. PubMed ID: 29411260
[TBL] [Abstract][Full Text] [Related]
8. Intralesional rituximab: a new therapeutic approach for patients with conjunctival lymphomas.
Ferreri AJ; Govi S; Colucci A; Crocchiolo R; Modorati G
Ophthalmology; 2011 Jan; 118(1):24-8. PubMed ID: 20709407
[TBL] [Abstract][Full Text] [Related]
9. Localized conjunctival mucosa-associated lymphoid tissue (MALT) lymphoma is amenable to local chemotherapy.
Yu CS; Chiu SI; Ng CS; Chan HH; Tse RK
Int Ophthalmol; 2008 Feb; 28(1):51-4. PubMed ID: 17589808
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up results of observation or radiation for conjunctival malignant lymphoma.
Matsuo T; Yoshino T
Ophthalmology; 2004 Jun; 111(6):1233-7. PubMed ID: 15177977
[TBL] [Abstract][Full Text] [Related]
11. Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction.
Kim HJ; Shields CL; Shah SU; Kaliki S; Lally SE
Ophthalmology; 2012 May; 119(5):938-44. PubMed ID: 22361315
[TBL] [Abstract][Full Text] [Related]
12. Systemic Rituximab Immunotherapy in the Management of Primary Ocular Adnexal Lymphoma: Single Institution Experience.
Tuncer S; Tanyıldız B; Basaran M; Buyukbabani N; Dogan O
Curr Eye Res; 2015; 40(8):780-5. PubMed ID: 25247376
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b.
Schechter BA; Koreishi AF; Karp CL; Feuer W
Ophthalmology; 2008 Aug; 115(8):1291-6, 1296.e1. PubMed ID: 18187195
[TBL] [Abstract][Full Text] [Related]
14. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.
Krilis M; Tsang H; Coroneo M
Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834
[TBL] [Abstract][Full Text] [Related]
15. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
[TBL] [Abstract][Full Text] [Related]
16. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex.
Finger PT; Sedeek RW; Chin KJ
Am J Ophthalmol; 2008 Jan; 145(1):124-129. PubMed ID: 17981257
[TBL] [Abstract][Full Text] [Related]
17. Intra-lesional interferon injection for recurrent conjunctival MALT lymphoma.
Zayed M; Sears K; Salvi SM; Rundle PA; Rennie IG; Mudhar HS
Eye (Lond); 2013 May; 27(5):680-2. PubMed ID: 23558211
[No Abstract] [Full Text] [Related]
18. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
19. Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma).
Son SH; Choi BO; Kim GW; Yang SW; Hong YS; Choi IB; Kim YS
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):86-91. PubMed ID: 19632068
[TBL] [Abstract][Full Text] [Related]
20. Paediatric and adolescent elevated conjunctival lesions in the plical area: lymphoma or reactive lymphoid hyperplasia?
Beykin G; Pe'er J; Amir G; Frenkel S
Br J Ophthalmol; 2014 May; 98(5):645-50. PubMed ID: 24162623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
